First, the definition of ER positivity and HER2 overexpression was somewhat different between our series and the 125 Chinese breast cancers (GSE5460, Lu et al. dataset), which hampered the comparability between these two independent studies. This evidence concerns the gene ERBB2 and breast carcinoma.